Sign In
Buy AMRX
$18.09
+0.170 (+0.95%)
At Close: Jul 27, 2026
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
04:05pm, Thursday, 08'th Feb 2024
BRIDGEWATER, N.J., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”) today announced that it has provided a Complete Response resubmissi
The Jobs Report Blows Away Forecasts
09:26pm, Friday, 02'nd Feb 2024
January's payrolls report shows 353,000 jobs
Amneal to Report Fourth Quarter and Full Year 2023 Results on March 1, 2024
04:05pm, Wednesday, 31'st Jan 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its fourth quarter and full year 2023 financial results on Friday, March 1
GSK, Amneal, Kaléo delist patents from FDA's orange book
12:15pm, Friday, 22'nd Dec 2023
Pharmaceutical companies, GSK (GSK), Amneal Pharmaceuticals (AMRX) and Kaléo have agreed to delist some of their patents from the FDA's orange book. GSK withdrew four inhaler patents and Amneal withd
Amneal Pharmaceuticals: By Most Measures, A Fundamentally Undervalued Company
10:23pm, Saturday, 09'th Dec 2023
Amneal Pharmaceuticals' stock price has been on a strong bull run, now exceeding $5 per share and up over >145% this year. The company experienced losses in 2018 and 2019 but has since seen improvemen
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Call Transcript
03:19pm, Tuesday, 07'th Nov 2023
Amneal Pharmaceuticals, Inc. (NYSE:AMRX ) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Anthony DiMeo - Head-Investor Relations Chirag Patel - Co-Founder & Co-Chief
Amneal (AMRX) Upgraded to Buy: Here's Why
01:32pm, Wednesday, 25'th Oct 2023
Amneal (AMRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year?
11:22am, Wednesday, 25'th Oct 2023
Here is how Amneal Pharmaceuticals (AMRX) and KalVista Pharmaceuticals, Inc. (KALV) have performed compared to their sector so far this year.
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?
01:31pm, Tuesday, 17'th Oct 2023
Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Amneal (AMRX)
10:32am, Friday, 06'th Oct 2023
Amneal (AMRX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading
Penny Stocks To Buy? 5 To Watch With Big News This Week
02:08pm, Monday, 07'th Aug 2023
Investors often rely on stock market news to stay abreast of everything, ranging from low-cost penny stocks to industry giants such as Apple or Tesla. It's no secret that news can ignite excitement an
Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Top Estimates
09:02am, Friday, 04'th Aug 2023
Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.19 per share a year ago.
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?
01:42pm, Friday, 21'st Jul 2023
Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Shares of Amneal Pharmaceuticals Are Plunging Wednesday
01:23pm, Wednesday, 05'th Jul 2023
Amneal has more than 270 products. On Tuesday, the company launched a generic for Xyrem to treat excessive daytime sleepiness.
Amneal (AMRX) Shares Down on CRL for Parkinson's Disease Drug
10:47am, Wednesday, 05'th Jul 2023
Amneal (AMRX) suffers a setback as the FDA issues a complete response letter (CRL) to its new drug application (NDA) for IPX203 for treating Parkinson's disease.
